Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial

OBJECTIVE: To assess associations between the extent of fibrotic interstitial lung disease (ILD) and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients with systemic sclerosis-associated ILD (SSc-ILD) in the SENSCIS trial. MATERIAL AND METHODS: We used generalized ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Denton, Christopher P, Goh, Nicole S, Humphries, Stephen M, Maher, Toby M, Spiera, Robert, Devaraj, Anand, Ho, Lawrence, Stock, Christian, Erhardt, Elvira, Alves, Margarida, Wells, Athol U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152288/
https://www.ncbi.nlm.nih.gov/pubmed/36111858
http://dx.doi.org/10.1093/rheumatology/keac535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152288/
https://www.ncbi.nlm.nih.gov/pubmed/36111858
http://dx.doi.org/10.1093/rheumatology/keac535

Ejemplares similares